EHMT2 and acute myeloid leukemia: Furthermore H3K9methylation (both di- and tri-methylation) and HMTases G9a/GLP and SetDB1 are known to inhibit pluripotent stem cell features [4, 74] suggesting that spreading of H3K9me2 would promote myeloid differentiation and restrict AML progression.